Effectsof Estrone, Estradiol,and Estriolon Hormone responsiveHuman Breast Cancer in Long-TermTissue Cultureâ€

SUMMARY The effects of estrone, estnadiol, and estniobon MCF-7 human breast cancer are compared. In this estrogen-me sponsive cell line, all three estrogens are capable of induc ing equivalent stimulation of amino acid and nucleoside incorporation. Estriol is capable of partially overcoming antiestrogen inhibition with Tamoxifen (ICI 46474), even when antiestrogen is present in 1000-fold excess. Antiestro gen effects are completely overcome by 100-fold less es tniol. Studies of metabolism of estrogens by MCF-7 cells revealedno conversionof estniob to eitherestroneonestna diol.Allthreesteroids bindtoa high-affinity estrogenne ceptomfound in these cells. The apparent dissociation con stant is lower for estradiol than for estrone and estriol, but all three bind to an equal number of sites when saturating concentrations are used. Tnitiated estrogens used in bind ing studies were shown to be nadiochemically pure. We conclude that estniol can bind to estrogen receptor and stimulate human breast cancer in tissue culture. Our data do not support an antiestnogenic role for estniol in human breastcancer.

[1]  C. Osborne,et al.  In vitro model systems for the study of hormone-dependent human breast cancer. , 1977, The New England journal of medicine.

[2]  M. Lippman,et al.  A simple computer program for quantitation and Scatchard analysis of steroid receptor proteins. , 1977, Journal of steroid biochemistry.

[3]  C. Osborne,et al.  Hormone responsive human breast cancer in long-term tissue culture: effect of insulin. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Lippman,et al.  A demonstration of androgen and estrogen receptors in a human breast cancer using a new protamine sulfate assay , 1976, Cancer.

[5]  H. Bradlow,et al.  Hormone profiles in hormone-dependent cancers. , 1975, Cancer research.

[6]  H. Lemon Estriol prevention of mammary carcinoma induced by 7,12-dimethylbenzanthracene and procarbazine. , 1975, Cancer research.

[7]  B. Mobbs,et al.  Estrogen-binding in vitro by DMBA-induced rat mammary tumors: its relationship to hormone responsiveness. , 1974, European journal of cancer.

[8]  W. McGuire,et al.  Improved sensitivity in the measurement of estrogen receptor in human breast cancer. , 1973, The Journal of clinical endocrinology and metabolism.

[9]  A. Long,et al.  A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.

[10]  G. Flickinger,et al.  Column chromatography of steroids on Sephadex LH-20. , 1971, The Journal of clinical endocrinology and metabolism.

[11]  D. Griswold,et al.  Studies of the kinetics of growth and regression of 7,12-dimethylbenz(alpha)anthracene-induced mammary adenocarcinoma in Sprague-Dawley rats. , 1970, Cancer research.

[12]  J. Adams,et al.  PARAENDOCRINE BEHAVIOUR OF HUMAN BREAST CARCINOMA: IN VITRO TRANSFORMATION OF STEROIDS TO PHYSIOLOGICALLY ACTIVE HORMONES , 1968 .

[13]  P. Mozden,et al.  Reduced estriol excretion in patients with breast cancer prior to endocrine therapy. , 1966, JAMA.

[14]  C. Hopkins,et al.  II. URINARY EXCRETION OF ESTRONE, ESTRADIOL, AND ESTRIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE. , 1965, American journal of obstetrics and gynecology.

[15]  C. Hopkins,et al.  URINARY EXCRETION OF ESTRONE, ESTRADIOL AND ESTRIOL BY PATIENTS WITH PROSTATIC CANCER AND BENIGN PROSTATIC HYPERTROPHY. , 1965, The Journal of urology.

[16]  L. Risholm,et al.  OOPHORECTOMY AND CORTISONE TREATMENT AS A METHOD OF ELIMINATING OESTROGEN PRODUCTION IN PATIENTS WITH BREAST CANCER. , 1964, Acta endocrinologica.

[17]  G. Bacigalupo,et al.  [Studies on the estrogen excretion in urine in mastopathy]. , 1960, Klinische Wochenschrift.

[18]  I. Bersohn,et al.  Urinary oestrogen levels in myocardial infarction. , 1958, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[19]  E. Jensen,et al.  THE DEPRESSION OF ESTRONE-INDUCED UTERINE GROWTH BY PHENOLIC ESTROGENS WITH OXYGENATED FUNCTIONS AT POSITIONS 6 OR 16: THE IMPEDED ESTROGENS , 1955, The Journal of experimental medicine.

[20]  F. Hisaw,et al.  Interaction of estrogens on uterine growth. , 1954, The Journal of clinical endocrinology and metabolism.

[21]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .